Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 4/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 5/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | ALPL | P05186 | 1/20 | 0.44 |
| ▸ | ALPI | P09923 | 1/20 | 0.44 |
| ▸ | ALPG | P10696 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | GBA1 | P04062 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | NOS3 | P29474 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10332678 | 0.86 | CYP2C19 (0.52) | CYP2C19CYP1A2CYP2D6CYP3A4CYP2C9 | |
| SCHEMBL3078147 | 0.85 | CYP2C19 (0.64) | CYP2C19CYP1A2CYP2D6CYP3A4CYP2C9 | |
| SCHEMBL7391468 | 0.85 | CYP2C19 (0.50) | CYP2C19CYP1A2CYP2D6CYP3A4CYP2C9 | |
| SCHEMBL7388300 | 0.83 | CYP2C19 (0.48) | CYP2C19CYP1A2CYP2D6CYP3A4CYP2C9 | |
| SCHEMBL1462235 | 0.81 | CYP1A2 (0.61) | CYP2C19CYP1A2CYP2D6CYP3A4CYP2C9 | |
| (Chloromethyl)Benzene SCHEMBL4625090 | 0.81 | CYP2C19 (0.45) | CYP2C19CYP1A2CYP2D6CYP3A4CYP2C9 | |
| SCHEMBL6306047 | 0.80 | CYP2C19 (0.59) | CYP2C19CYP1A2CYP2D6CYP3A4CYP2C9 | |
| SCHEMBL231574 | 0.80 | CYP2C19 (0.48) | CYP2C19CYP1A2CYP2D6CYP3A4CYP2C9 | |
| SCHEMBL7909121 | 0.80 | CYP2C19 (0.59) | CYP2C19CYP1A2CYP2D6CYP3A4CYP2C9 | |
| SCHEMBL206 | 0.79 | CYP2C19 (0.56) | CYP2C19CYP1A2CYP2D6CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-57122064-A | — | — | None | — | — | JP | disclosed |
| US-12559852-B2 | Composition for tin-silver alloy electroplating comprising a complexing agent | BASF SE (DE) | 2026-02-24 | — | — | US | disclosed |
| CN-114316397-B | Double-functional polybutadiene rubber/graphene oxide composite material and preparation method thereof | 中国石油天然气股份有限公司 | 2024-03-01 | — | — | CN | disclosed |
| US-20240060201-A1 | COMPOSITION FOR TIN-SILVER ALLOY ELECTROPLATING COMPRISING A COMPLEXING AGENT | BASF SE (DE) | 2024-02-22 | — | — | US | disclosed |
| EP-4031695-A1 | COMPOSITION FOR TIN-SILVER ALLOY ELECTROPLATING COMPRISING A COMPLEXING AGENT | BASF SE (DE) | 2022-07-27 | — | — | EP | disclosed |
| CN-114402096-A | Composition for tin-silver alloy electroplating comprising complexing agent | 巴斯夫欧洲公司 | 2022-04-26 | — | — | CN | disclosed |
| CN-114316397-A | Bifunctional polybutadiene rubber/graphene oxide composite material and preparation method thereof | 中国石油天然气股份有限公司 | 2022-04-12 | — | — | CN | disclosed |
| CN-114316381-A | Tire bead protection rubber and preparation method thereof | 中国石油天然气股份有限公司 | 2022-04-12 | — | — | CN | disclosed |
| WO-2021052817-A1 | COMPOSITION FOR TIN-SILVER ALLOY ELECTROPLATING COMPRISING A COMPLEXING AGENT | BASF SE (DE) | 2021-03-25 | — | — | WO | disclosed |
| CN-106565904-B | Bifunctionalized styrene-butadiene polymer, preparation method thereof, rubber composition and vulcanized rubber | 中国石油天然气股份有限公司 | 2019-03-12 | — | — | CN | disclosed |
| US-20030055297-A1 | An alkyl, cycloalkyl, arylalkyl dihydroxy compound useful as intermediates; a cost-effective preparation | ABBOTT LABORATORIES | 2003-03-20 | — | — | US | disclosed |
| WO-2002081441-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED PYRROLIDINE NEURAMINIDASE INHIBITORS | ABBOTT LABORATORIES (US) | 2002-10-17 | — | — | WO | disclosed |
| US-4724235-A | N-(arylthioalkyl)-N'-(aminoalkyl)ureas useful in the treatment of arrhythmia | A. H. ROBINS COMPANY, INCORPORATED (US) | 1988-02-09 | — | — | US | disclosed |
| US-4597902-A | TREATMENT OF CARDIAC ARRHYTHMIAS | A. H. ROBINS COMPANY, INCORPORATED (US) | 1986-07-01 | — | — | US | disclosed |
| EP-0066415-B1 | N-(ARYLTHIOALKYL)-N'-(AMINOALKYL)UREAS | A.H. ROBINS COMPANY, INCORPORATED (US) | 1985-10-02 | — | — | EP | disclosed |
| US-4449005-A | REACTING A CHLOROETHYL SULFIDE AND QUATERNARY AMMONIUM OR QUATERNARY PHOSPHONIUM FLUORIDE TO PRODUCE A VINYL SULFIDE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1984-05-15 | — | — | US | disclosed |
| EP-0066415-A2 | N-(arylthioalkyl)-N'-(aminoalkyl)ureas | A.H. ROBINS COMPANY, INCORPORATED (US) | 1982-12-08 | — | — | EP | disclosed |
| JP-S57122064-A | GUANIDINE DERIVATIVE AND ITS PREPARATION | FUJIMOTO SEIYAKU KK | 1982-07-29 | — | — | JP | disclosed |
| US-4182891-A | ENZYME INHIBITORS, IMMUNOSUPPRESSANTS, CONTROL OF NEOPLASTIC GROWTH | MERRELL TORAUDE ET COMPAGNIE (FR) | 1980-01-08 | — | — | US | disclosed |
| US-4139563-A | ENZYME INHIBITORS, ANTIFERTILITY AGENTS, IMMUNOSUPPRESSIVES, ANTITUMOR AGENTS | MERRELL TORAUDE ET COMPAGNIE (FR) | 1979-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559852-B2 | Composition for tin-silver alloy electroplating comprising a complexing agent | SLC13A3, GNA11, AP3D1 | CYP2C19 1814/4885CYP1A2 1677/4885CYP2D6 1745/4885 |
| US-20240060201-A1 | COMPOSITION FOR TIN-SILVER ALLOY ELECTROPLATING COMPRISING A COMPLEXING AGENT | SLC39A11, SCN11A, S100A11 | CYP2C19 3371/4885CYP1A2 2902/4885CYP2D6 2646/4885 |
| US-20030055297-A1 | An alkyl, cycloalkyl, arylalkyl dihydroxy compound useful as intermediates; a cost-effective preparation | NEU4, NEU2, NEU1 | CYP2C19 228/4885CYP1A2 315/4885CYP2D6 364/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.